Related Experiment Video
Updated: Aug 20, 2025
07:58
Behavioral and Network Pharmacology-Based Analyses for the Traditional Mongolian Medicine Zadi-5 in a Rat Model of Depression
Published on: February 24, 2023
575
Studies on Apigenin and Its Biological and Pharmacological Activity in Brain Disorders
Vishal Kumar1, Satyabrata Kundu1
1Department of Pharmacology, ISF College of Pharmacy Moga, Punjab 142001 India.
Advanced Pharmaceutical Bulletin
|November 23, 2022
Abstract
No abstract available in PubMed .
Related Concept Videos
00:49The Blood-brain Barrier
48.0K
Overview
48.0K
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
183
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
183
01:30Indirect-Acting Cholinergic Agonists: Pharmacological Actions
749
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
749